Gilead Sciences
GILD
#111
Rank
S$214.18 B
Marketcap
S$172.56
Share price
-1.29%
Change (1 day)
27.65%
Change (1 year)

Market capitalization of Gilead Sciences (GILD)

Market cap: S$214.18 Billion

As of April 2026 Gilead Sciences has a market cap of S$214.18 Billion. This makes Gilead Sciences the world's 111th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Gilead Sciences from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026S$214.18 B7.82%
2025S$198.65 B24.61%
2024S$159.42 B19.59%
2023S$133.31 B-7.65%
2022S$144.35 B17.27%
2021S$123.09 B27.41%
2020S$96.61 B-12.89%
2019S$110.90 B1.24%
2018S$109.55 B-12.48%
2017S$125.16 B-8.33%
2016S$136.54 B-32.92%
2015S$203.53 B9.02%
2014S$186.69 B27.88%
2013S$145.99 B113.99%
2012S$68.22 B71.36%
2011S$39.81 B6.35%
2010S$37.43 B-31.5%
2009S$54.65 B-17.92%
2008S$66.59 B8.28%
2007S$61.49 B33.95%
2006S$45.91 B14.09%
2005S$40.23 B57.06%
2004S$25.61 B21.33%
2003S$21.11 B81.14%
2002S$11.65 B-0.73%
2001S$11.74 B73.27%
2000S$6.77 B70.55%
1999S$3.97 B90.86%
1998S$2.08 B7.45%
1997S$1.93 B92.58%
1996S$1.00 B

End of Day market cap according to different sources

On Apr 19th, 2026 the market cap of Gilead Sciences was reported to be:

S$217.01 Billion
by Nasdaq info icon info icon
S$216.97 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$706.07 B 229.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$198.81 B-7.17%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$457.62 B 113.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.045 T 388.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$239.73 B 11.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
S$34.17 B-84.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
S$25.80 B-87.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
S$141.87 B-33.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$367.70 B 71.68%๐Ÿ‡บ๐Ÿ‡ธ USA